Optimization of IV Ketamine for Treatment Resistant Depression

NCT00768430 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder (MDD)
Treatment Resistant Depression (TRD)

Interventions

DRUG: Ketamine
DRUG: Midazolam

Sponsor

Baylor College of Medicine

Collaborators

[object Object]